These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10874439)

  • 1. [The economic impact of inadequate prescriptions].
    Montravers P
    Ann Fr Anesth Reanim; 2000 May; 19(5):388-94. PubMed ID: 10874439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Is it possible to rationalize antibiotic usage in hospitals?].
    Ribas J; Trilla A
    Enferm Infecc Microbiol Clin; 1995 Dec; 13(10):577-80. PubMed ID: 8808472
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effective antibiotic prescribing.
    Gleckman R; Gantz NM
    Pharmacotherapy; 1983; 3(4):239-48. PubMed ID: 6412217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacoeconomical analysis of antibiotic use at the Clinic For Infectious Diseases of the Clinical Center of Vojvodina].
    Stefan-Mikić S; Jovanović J; Jovanović N; Sević S; Vukadinov J; Miucin-Vukadinović I
    Med Pregl; 2008; 61 Suppl 1():40-9. PubMed ID: 19248639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacoeconomics of antibacterial treatment.
    Davey PG; Malek MM; Parker SE
    Pharmacoeconomics; 1992 Jun; 1(6):409-37. PubMed ID: 10147022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of an infectious disease consulting service on quality and costs of antibiotic prescriptions in a university hospital.
    Lemmen SW; Becker G; Frank U; Daschner FD
    Scand J Infect Dis; 2001; 33(3):219-21. PubMed ID: 11303814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial stewardship: bridging the gap between quality care and cost.
    Goff DA
    Curr Opin Infect Dis; 2011 Feb; 24 Suppl 1():S11-20. PubMed ID: 21200180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excessive antibiotic use for acute respiratory infections in the United States.
    Gonzales R; Malone DC; Maselli JH; Sande MA
    Clin Infect Dis; 2001 Sep; 33(6):757-62. PubMed ID: 11512079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Main variables in the economic cost of treating an infection].
    Grau S
    Enferm Infecc Microbiol Clin; 2017 Jan; 35 Suppl 1():41-45. PubMed ID: 28129821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial resistance: are we at the dawn of the post-antibiotic era?
    Williams DN
    J R Coll Physicians Edinb; 2016 Sep; 46(3):150-156. PubMed ID: 27959347
    [No Abstract]   [Full Text] [Related]  

  • 11. Economic impact simulation analysis of use of tigecycline, as appropriate, in first-course antibiotic therapy for complicated intra-abdominal infections in intensive care patients.
    Ancona F
    Minerva Med; 2010 Oct; 101(5):319-28. PubMed ID: 21048554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in primary care antibiotic prescribing in England 1994-1998.
    Unsworth L; Walley T
    Pharmacoepidemiol Drug Saf; 2001; 10(4):309-14. PubMed ID: 11760492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic resistance: who will pay the bills?
    Zaoutis TE
    Clin Infect Dis; 2009 Oct; 49(8):1185-6. PubMed ID: 19739974
    [No Abstract]   [Full Text] [Related]  

  • 14. Prescribing quality is not synonymous with cost minimization for antibiotics.
    Millar MR; Russell E; Karcher AM; Neville L; Portia OB
    J Antimicrob Chemother; 2001 Mar; 47(3):367-8. PubMed ID: 11222579
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibiotic prescribing--are there lessons for physicians?
    Nathwani D; Davey P
    QJM; 1999 May; 92(5):287-92. PubMed ID: 10615484
    [No Abstract]   [Full Text] [Related]  

  • 16. [Phamacoeconomic analysis of antibiotics use in the Clinical Center of Vojvodina].
    Stefan-Mikić S; Jovanović J; Jovanović N; Aleksić-Dordević M; Cvjetković D; Krajcir I
    Med Pregl; 2008; 61 Suppl 1():50-8. PubMed ID: 19248640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Strategy for empirical antibiotic therapy re-evaluation: do you have to change a successful therapy?].
    Veber B
    Ann Fr Anesth Reanim; 2004 Jun; 23(6):654-7. PubMed ID: 15234739
    [No Abstract]   [Full Text] [Related]  

  • 18. [7/10 Antibiotic drug therapy and infectious risk].
    Soins; 2007 Sep; (718):59-60. PubMed ID: 17970578
    [No Abstract]   [Full Text] [Related]  

  • 19. Economic impact of standard antibiotic therapy combined with amikacin, in clinical unit, Lodz, Poland--part II.
    Kusowska J
    Acta Pol Pharm; 2005; 62(6):491-5. PubMed ID: 16583990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic impact of standard antibiotic therapy combined with amikacin, in clinical unit, Lodz, poland--part I.
    Kusowska J
    Acta Pol Pharm; 2005; 62(6):485-90. PubMed ID: 16583989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.